Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma

2020 ◽  
Vol 108 (1) ◽  
pp. 178-188 ◽  
Author(s):  
Christopher M. Wright ◽  
Michael J. LaRiviere ◽  
Jonathan A. Baron ◽  
Chibueze Uche ◽  
Ying Xiao ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Aggressive B Cell Lymphoma

scholarly journals Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy

2019 ◽  
Vol 25 (11) ◽  
pp. e344-e351 ◽  
Author(s):  
Michael Byrne ◽  
Olalekan O. Oluwole ◽  
Bipin Savani ◽  
Navneet S. Majhail ◽  
Brian T. Hill ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document